The Government Pharmaceutical Organization (GPO) offers dismissed claims with a group of doctors that the shortage of antiviral medications for Covid-19 is imminent due to low stocks, saying it is supplying many drugs to private hospitals nationwide.
Under a plan to deliver 25 million favipiravir tablets to health units responsible for controlling the drug and redistributing it in order to hospitals in their areas, 3. 7 mil tablets have already been delivered to these units across the nation, said GPO deputy director, Sirikul Metheerangsan.
Submission of the rest of the pills will begin tomorrow and won’t stop until all supplies from the drug are delivered to their destinations, the lady said.
The GPO will certainly at the same time order more materials to produce the drug to ensure adequate supplies, which will be maintained in line with the Covid-19 scenario.
Also, under another plan to supply the Ministry associated with Public Health with 5 million molnupiravir capsules, the GPO has already delivered two million since Tuesday, she said.
The rest are now being procured and will be shipped by the end of this 30 days, she said.
Aside from providing these drugs to state healthcare units, the GPO is also checking their actual use. This is required to adjust stock requirements as the Covid-19 situation retains changing, she mentioned.
The particular Rural Doctor Society (RDS) had warned stocks of favipiravir and monulpiravir were running low along with a shortage was expected in days.
Citing a message sent by the ministry to provincial health offices and medical center directors nationwide, the particular RDS said private hospitals were asked by ministry to try their particular very best to extra favipiravir for Covid-19 patients who are below 18 years of age.
The demand was aimed at ensuring enough for young kids before more items arrived at hospitals within about a week, said the RDS.